R. Kirk Huntsman
2023
In 2023, R. Kirk Huntsman earned a total compensation of $657.7K as Chief Executive Officer at Vivos Therapeutics, a 30% decrease compared to previous year.
Compensation breakdown
Change in Pension Value and Nonqualified Deferred Compensation Earnings | $175,543 |
---|---|
Salary | $463,393 |
Other | $18,765 |
Total | $657,701 |
Huntsman received $463.4K in salary, accounting for 70% of the total pay in 2023.
Huntsman also received $175.5K of change in pension value and nonqualified deferred compensation earnings and $18.8K in other compensation.
Rankings
In 2023, R. Kirk Huntsman's compensation ranked 1,703rd out of 2,990 executives tracked by ExecPay. In other words, Huntsman earned more than 43.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,703 | 43rd |
Manufacturing | 993 | 40th |
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 133 | 48th |
Surgical, Medical, And Dental Instruments And Supplies | 90 | 52nd |
Surgical and Medical Instruments and Apparatus | 76 | 47th |
Huntsman's colleagues
We found one more compensation record of an executive who worked with R. Kirk Huntsman at Vivos Therapeutics in 2023.
2023
Bradford Amman
Vivos Therapeutics